Project: Gut-To-Blood: a platform for oral systemic delivery of targeted therapies

Acronym G2B (Reference Number: 114171)
Duration 01/10/2020 - 01/10/2023
Project Topic The partners are going to develop a unique platform for oral systemic delivery of targeted therapies. At the end of the project a Gut-To-Blood (G2B) Shuttle will be ready for partnering with Pharmaceutical companies to develop orally available molecules to treat chronic systemic diseases such as inflammatory autoimmune diseases, metabolic diseases, genetic disorders, etc… A second deliverable will be a molecule to treat rheumatoid arthritis (RA), developed as a proof-of-concept of the platform.
Network Eurostars 2
Call Eurostars Cut–off 13

Project partner

Number Name Role Country
1 Affilogic SAS Coordinator France
2 ARTOIS UNIVERSITY, Public Scientific Cultural and Professional Establishment Partner France
4 University of Geneva Partner Switzerland